Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385241314> ?p ?o ?g. }
- W4385241314 endingPage "1052" @default.
- W4385241314 startingPage "1052" @default.
- W4385241314 abstract "Recently, stable gastric pentadecapeptide BPC 157 therapy by activation of collateral pathways counteracted various occlusion/occlusion-like syndromes, vascular, and multiorgan failure, and blood pressure disturbances in rats with permanent major vessel occlusion and similar procedures disabling endothelium function. Thereby, we revealed BPC 157 cytoprotective therapy with strong vascular rescuing capabilities in glaucoma therapy. With these capabilities, BPC 157 therapy can recover glaucomatous rats, normalize intraocular pressure, maintain retinal integrity, recover pupil function, recover retinal ischemia, and corneal injuries (i.e., maintained transparency after complete corneal abrasion, corneal ulceration, and counteracted dry eye after lacrimal gland removal or corneal insensitivity). The most important point is that in glaucomatous rats (three of four episcleral veins cauterized) with high intraocular pressure, all BPC 157 regimens immediately normalized intraocular pressure. BPC 157-treated rats exhibited normal pupil diameter, microscopically well-preserved ganglion cells and optic nerve presentation, normal fundus presentation, nor- mal retinal and choroidal blood vessel presentation, and normal optic nerve presentation. The one episcleral vein rapidly upgraded to accomplish all functions in glaucomatous rats may correspond with occlusion/occlusion-like syndromes of the activated rescuing collateral pathway (azygos vein direct blood flow delivery). Normalized intraocular pressure in glaucomatous rats corresponded to the counteracted intra-cranial (superior sagittal sinus), portal, and caval hypertension, and aortal hypotension in occlusion/occlusion-like syndromes, were all attenuated/eliminated by BPC 157 therapy. Furthermore, given in other eye disturbances (i.e., retinal ischemia), BPC 157 instantly breaks a noxious chain of events, both at an early stage and an already advanced stage. Thus, we further advocate BPC 157 as a therapeutic agent in ocular disease." @default.
- W4385241314 created "2023-07-26" @default.
- W4385241314 creator A5006573657 @default.
- W4385241314 creator A5006884333 @default.
- W4385241314 creator A5007528516 @default.
- W4385241314 creator A5017246332 @default.
- W4385241314 creator A5017342414 @default.
- W4385241314 creator A5017608213 @default.
- W4385241314 creator A5023841591 @default.
- W4385241314 creator A5033496447 @default.
- W4385241314 creator A5033781641 @default.
- W4385241314 creator A5040344481 @default.
- W4385241314 creator A5043779562 @default.
- W4385241314 creator A5046821743 @default.
- W4385241314 creator A5049495381 @default.
- W4385241314 creator A5051423361 @default.
- W4385241314 creator A5055348880 @default.
- W4385241314 creator A5058152265 @default.
- W4385241314 creator A5060622948 @default.
- W4385241314 creator A5066205799 @default.
- W4385241314 creator A5072968499 @default.
- W4385241314 creator A5079605303 @default.
- W4385241314 creator A5086021190 @default.
- W4385241314 creator A5090482255 @default.
- W4385241314 creator A5090593580 @default.
- W4385241314 creator A5092433141 @default.
- W4385241314 date "2023-07-24" @default.
- W4385241314 modified "2023-10-14" @default.
- W4385241314 title "Stable Gastric Pentadecapeptide BPC 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions" @default.
- W4385241314 cites W1380226 @default.
- W4385241314 cites W143914307 @default.
- W4385241314 cites W1488353016 @default.
- W4385241314 cites W1495999720 @default.
- W4385241314 cites W1520213793 @default.
- W4385241314 cites W1532865161 @default.
- W4385241314 cites W1557246082 @default.
- W4385241314 cites W1561418783 @default.
- W4385241314 cites W1573690431 @default.
- W4385241314 cites W1575402497 @default.
- W4385241314 cites W1589717509 @default.
- W4385241314 cites W1600107915 @default.
- W4385241314 cites W1601769224 @default.
- W4385241314 cites W1647673633 @default.
- W4385241314 cites W1709624 @default.
- W4385241314 cites W1750430662 @default.
- W4385241314 cites W1842846843 @default.
- W4385241314 cites W195072307 @default.
- W4385241314 cites W1968544835 @default.
- W4385241314 cites W1971122873 @default.
- W4385241314 cites W1973607009 @default.
- W4385241314 cites W1974896557 @default.
- W4385241314 cites W198132779 @default.
- W4385241314 cites W1982367147 @default.
- W4385241314 cites W1982422365 @default.
- W4385241314 cites W1983843189 @default.
- W4385241314 cites W1985794479 @default.
- W4385241314 cites W1991757771 @default.
- W4385241314 cites W1995875574 @default.
- W4385241314 cites W1995888380 @default.
- W4385241314 cites W1996114536 @default.
- W4385241314 cites W1997366340 @default.
- W4385241314 cites W1999193613 @default.
- W4385241314 cites W1999304281 @default.
- W4385241314 cites W2000121960 @default.
- W4385241314 cites W2000801223 @default.
- W4385241314 cites W2000935282 @default.
- W4385241314 cites W2005257947 @default.
- W4385241314 cites W2006442900 @default.
- W4385241314 cites W2010315025 @default.
- W4385241314 cites W2013311203 @default.
- W4385241314 cites W2013383108 @default.
- W4385241314 cites W2014954772 @default.
- W4385241314 cites W2016477997 @default.
- W4385241314 cites W2019395527 @default.
- W4385241314 cites W2025420513 @default.
- W4385241314 cites W2027057010 @default.
- W4385241314 cites W2027140863 @default.
- W4385241314 cites W2029444159 @default.
- W4385241314 cites W2029522517 @default.
- W4385241314 cites W2029812351 @default.
- W4385241314 cites W2030349544 @default.
- W4385241314 cites W2032268647 @default.
- W4385241314 cites W2034300124 @default.
- W4385241314 cites W2039145880 @default.
- W4385241314 cites W2044091567 @default.
- W4385241314 cites W2046442726 @default.
- W4385241314 cites W2048653226 @default.
- W4385241314 cites W2050879337 @default.
- W4385241314 cites W2055262503 @default.
- W4385241314 cites W2058683624 @default.
- W4385241314 cites W2058922312 @default.
- W4385241314 cites W2061934018 @default.
- W4385241314 cites W2062455504 @default.
- W4385241314 cites W2062928940 @default.
- W4385241314 cites W2063063805 @default.
- W4385241314 cites W2063435261 @default.
- W4385241314 cites W2065005955 @default.
- W4385241314 cites W2065006321 @default.